CB2 Insights (CSE:CBII; OTCQB:CBTOF), a leading data-analytics company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, today reported its results for the fiscal year ending December 31, 2018. Additional information concerning the Company, including its unaudited condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for […]
The post CB2 Insights Announces FY2018 Financial Results appeared first on Technical420.
You may also like
-
Looking For Top Marijuana ETFs For Q2 2021 Right Now? 2 Leading ETFs To Watch
-
Marijuana Stocks To Watch This Month With Hidden Value
-
Are These Marijuana Penny Stocks A Buy Right Now?
-
Aphria Inc. (APHA) Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
-
The Time Is Now For Shareholders To Vote On The Tilray and Aphria MegaMerger